147 related articles for article (PubMed ID: 23423636)
1. Contrast medium injection protocol adjusted for body surface area in combined PET/CT.
Behrendt FF; Rebière M; Goedicke A; Pietsch H; Palmowski K; Kuhl CK; Mottaghy FM; Verburg FA
Eur Radiol; 2013 Jul; 23(7):1970-7. PubMed ID: 23423636
[TBL] [Abstract][Full Text] [Related]
2. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
3. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
4. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
[TBL] [Abstract][Full Text] [Related]
5. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
[TBL] [Abstract][Full Text] [Related]
6. PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.
Behrendt FF; Temur Y; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM
Eur Radiol; 2012 Nov; 22(11):2458-64. PubMed ID: 22661058
[TBL] [Abstract][Full Text] [Related]
7. Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.
Aschoff P; Plathow C; Beyer T; Lichy MP; Erb G; Öksüz MÖ; Claussen CD; Pfannenberg C
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):316-25. PubMed ID: 22124778
[TBL] [Abstract][Full Text] [Related]
8. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
10. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography (PET) attenuation correction artefacts in PET/CT and PET/MRI.
Buchbender C; Hartung-Knemeyer V; Forsting M; Antoch G; Heusner TA
Br J Radiol; 2013 May; 86(1025):20120570. PubMed ID: 23580397
[TBL] [Abstract][Full Text] [Related]
13. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
[TBL] [Abstract][Full Text] [Related]
14. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer T; Antoch G; Bockisch A; Stattaus J
J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
[TBL] [Abstract][Full Text] [Related]
15. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Veit-Haibach P; Treyer V; Strobel K; Soyka JD; Husmann L; Schaefer NG; Tschopp A; Hany TF
Abdom Imaging; 2010 Oct; 35(5):528-36. PubMed ID: 19593563
[TBL] [Abstract][Full Text] [Related]
17. Abdominal multi-detector row CT: effectiveness of determining contrast medium dose on basis of body surface area.
Onishi H; Murakami T; Kim T; Hori M; Osuga K; Tatsumi M; Higashihara H; Maeda N; Tsuboyama T; Nakamoto A; Tomoda K; Tomiyama N
Eur J Radiol; 2011 Dec; 80(3):643-7. PubMed ID: 20864283
[TBL] [Abstract][Full Text] [Related]
18. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
[TBL] [Abstract][Full Text] [Related]
19. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
20. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
